Company: SNWV
Filing Date: 2025-03-07
Form Type: 8-K
Source: 0001628280-25-011275
Chunk: 2

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-07
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01 Regulation FD Disclosure.

On March 4, 2025, the Company issued a press release announcing the listing of the Company’s common stock, par value $0.001 per share (the “ Common Stock”), on the Nasdaq Global Market (“ Nasdaq”) effective at the opening of trading on March 7, 2025 (the “ Uplisting”). The press release is furnished as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01 Other Events.